Search results
Results from the WOW.Com Content Network
Earlier this month, the health regulator approved updated COVID-19 vaccines made by Pfizer and Moderna targeting the KP.2 variant. JN.1 was the dominant strain in the United States earlier this year.
The updated vaccine is authorized for use in individuals 12 years of age and older and will target the JN.1 strain of the virus. Shares of the company were up 2.2% in extended trading after ...
Novavax’s vaccine is included in the recommendations issued by the U.S. Centers for Disease Control and Prevention (CDC) on June 27, 2024. ... the FDA granted Emergency Use Authorization to ...
The COVID-19 vaccination campaign in the United States is an ongoing mass immunization campaign for the COVID-19 pandemic in the United States.The Food and Drug Administration (FDA) first granted emergency use authorization to the Pfizer–BioNTech vaccine on December 10, 2020, [7] and mass vaccinations began four days later.
Vaccine Maitri (English: Vaccine Friendship) [166] is a humanitarian initiative undertaken by the Indian government to provide COVID-19 vaccines to countries around the world. [167] The government started providing vaccines from 20 January 2021. As of 6 March 2022, India had delivered around 16.3 cror doses of vaccines to 96 countries. [168]
The Sanofi–GSK COVID-19 vaccine, sold under the brand name VidPrevtyn Beta, is a COVID-19 vaccine developed by Sanofi Pasteur and GSK. [ 4 ] [ 5 ] The Sanofi–GSK COVID‑19 vaccine was approved for medical use in the European Union in November 2022.
The US Food and Drug Administration announced Friday that it had advised the makers of the Covid-19 vaccines to formulate their new shots to be a better match for the JN.1 lineage of the coronavirus.
Just like Pfizer and Moderna's updated vaccines, Novavax's new shot is tailored to fight the XBB.1.5 omicron subvariant, a close relative of the currently circulating strains.